In ATTAIN-1, nausea occurred in 28.9% to 35.9% of orforglipron-treated participants versus 10.4% with placebo, while vomiting was reported in 13.0% to 24.0% versus 4.0% with placebo
Without controlled body composition measurements, it's hard to interpret anecdotal reports
People who take GLP-1s often have obesity or diabetes
For instance, in one very small study involving 15 women, researchers found that while glycine didnt increase how much sleep the women got, it did seem to help them have a deeper sleep that left them feeling more rested in the morning
Medical Consultation Before starting Semaglutide treatment, consult with a healthcare professional who can evaluate your specific health status and needs
Does Anthem Medicare Advantage Cover Wegovy or Zepbound